Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BioNTech Raises FY2025 Sales Guidance from $1.787B-$2.314B to $3.040B-$3.274B

Author: Benzinga Newsdesk | November 03, 2025 07:00am
BioNTech (NASDAQ:BNTX) raises FY2025 sales outlook from $1.787 billion-$2.314 billion to $3.040 billion-$3.274 billion.

Posted In: BNTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist